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Background
Obstructive sleep apnea (OSA) is associated with an
increased risk of cardiovascular morbidity and mortality.
Previous transthoracic echocardiographic (TTE) studies
have demonstrated short term improvement in cardiovas-
cular remodeling in OSA patients on continuous positive
airway pressure (CPAP). However, due to the increased
prevalence of obesity in OSA patients, the quality of TTE
is often poor due to limited acoustic windows. Although
cardiac MRI (CMR) is considered the gold standard for the
noninvasive assessment of left ventricular (LV) dimen-
sions, volumes and ejection fraction (EF) due to its higher
spatial resolution, little is known about its utility in the
delineation of LV remodeling in OSA patients on CPAP
therapy over the long term.
Objectives
To determine the long term benefits of CPAP on both
right and left ventricular systolic and diastolic function in
patients with OSA using serial cardiac biomarkers,
echocardiography and CMR.
Methods
A prospective study of 50 OSA patients was performed
between 2007 and 2009 inclusive. Cardiac biomarkers
including C-reactive protein, N-terminal pro-B-type natri-
uretic peptide and troponin T were measured at baseline
and serially over one year. All patients underwent baseline
and serial TTE and CMR to assess for cardiac remodeling.
Results
All three cardiac biomarkers were within normal limits at
baseline and did not change significantly after 12 months
of CPAP therapy. As early as 3 months, TTE revealed an
improvement in left ventricular end-diastolic diameter
(59 ± 5 mm to 52 ± 4 mm), right ventricular end-diastolic
diameter (41 ± 3 mm to 36 ± 5 mm), and the degree of
pulmonary hypertension (54 ± 6 mmHg to 42 ± 4
mmHg), which continued to improve over one year of fol-
low-up. Left atrial filling pressures decreased from 16 ± 3
to 8 ± 2 at 12 months on TTE. On serial CMR, there was a
decrease in left atrial volume index (48 ± 2 ml/m2 at base-
line to 28 ± 2 ml/m2 at 12 months, p < 0.05), left ventricu-
lar end-diastolic volume (195 ± 10 at baseline to 130 ± 6
ml at 12 months, p < 0.05), and LV mass (185 ± 4 g/m2 at
baseline to 151 ± 3 g/m2 at 12 months, p < 0.05) (Table 1).
Conclusion
Using both TTE and CMR, the present study demonstrated
an improvement in systolic and diastolic functions as
early as 3 months into CPAP therapy, with continued
improvement in cardiac remodeling over the one-year
period.
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CMR parameters Baseline 6 months 12 months p value
LA and LV parameters
LAVI (ml/m2) 48 ± 2 35 ± 1* 28 ± 2* < 0.05
LVEDV (ml) 195 ± 10 150 ± 8* 130 ± 6* < 0.05
LVESV (ml) 58 ± 6 48 ± 5 46 ± 3 0.22
LVEF (%) 68 ± 2 68 ± 1 66 ± 2 0.75
LV mass (g/m2) 185 ± 4 162 ± 3* 151 ± 3* < 0.05
RA and RV parameters
RAVI (ml/m2) 48 ± 5 33 ± 2* 31 ± 3* < 0.05
RVEDD (mm) 44 ± 1 34 ± 2* 29 ± 2* < 0.05
Absolute p-values for the overall interaction of time are shown in the far right column. *p < 0.05 vs. at baseline.Page 2 of 2
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